Positive News For BioTelemetry Courtesy Of Blue Cross Blue Shield; Shares Up 15%

By: via Benzinga
Lake Street has reiterated its Buy rating and $24 price target on BioTelemetry, Inc. (NASDAQ: BEAT), saying that the Anthem Blue Cross ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.